These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7983769

  • 1. Inhibition of dengue virus by novel, modified antisense oligonucleotides.
    Raviprakash K, Liu K, Matteucci M, Wagner R, Riffenburgh R, Carl M.
    J Virol; 1995 Jan; 69(1):69-74. PubMed ID: 7983769
    [Abstract] [Full Text] [Related]

  • 2. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
    Hanecak R, Brown-Driver V, Fox MC, Azad RF, Furusako S, Nozaki C, Ford C, Sasmor H, Anderson KP.
    J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
    [Abstract] [Full Text] [Related]

  • 3. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
    Moulds C, Lewis JG, Froehler BC, Grant D, Huang T, Milligan JF, Matteucci MD, Wagner RW.
    Biochemistry; 1995 Apr 18; 34(15):5044-53. PubMed ID: 7536034
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1.
    Peyman A, Helsberg M, Kretzschmar G, Mag M, Grabley S, Uhlmann E.
    Biol Chem Hoppe Seyler; 1995 Mar 18; 376(3):195-8. PubMed ID: 7612196
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
    Park WS, Miyano-Kurosaki N, Abe T, Takai K, Yamamoto N, Takaku H.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):953-60. PubMed ID: 10772932
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides.
    Hatta T, Kim SG, Nakashima H, Yamamoto N, Sakamoto K, Yokoyama S, Takaku H.
    FEBS Lett; 1993 Sep 13; 330(2):161-4. PubMed ID: 7689980
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides.
    Jairath S, Vargas PB, Hamlin HA, Field AK, Kilkuskie RE.
    Antiviral Res; 1997 Feb 13; 33(3):201-13. PubMed ID: 9037376
    [Abstract] [Full Text] [Related]

  • 10. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T, Takai K, Nakada S, Yokota T, Takaku H.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):545-9. PubMed ID: 9125219
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
    Zelphati O, Zon G, Leserman L.
    Antisense Res Dev; 1993 Mar 17; 3(4):323-38. PubMed ID: 8155974
    [Abstract] [Full Text] [Related]

  • 13. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
    Lok CN, Viazovkina E, Min KL, Nagy E, Wilds CJ, Damha MJ, Parniak MA.
    Biochemistry; 2002 Mar 12; 41(10):3457-67. PubMed ID: 11876654
    [Abstract] [Full Text] [Related]

  • 14. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.
    Lisziewicz J, Sun D, Klotman M, Agrawal S, Zamecnik P, Gallo R.
    Proc Natl Acad Sci U S A; 1992 Dec 01; 89(23):11209-13. PubMed ID: 1454800
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
    Li G, Lisziewicz J, Sun D, Zon G, Daefler S, Wong-Staal F, Gallo RC, Klotman ME.
    J Virol; 1993 Nov 01; 67(11):6882-8. PubMed ID: 8411393
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
    Barnard DL, Sidwell RW, Xiao W, Player MR, Adah SA, Torrence PF.
    Antiviral Res; 1999 Apr 01; 41(3):119-34. PubMed ID: 10320045
    [Abstract] [Full Text] [Related]

  • 18. Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects.
    Meeker R, LeGrand G, Ramirez J, Smith T, Shih YH.
    J Neuroendocrinol; 1995 Jun 01; 7(6):419-28. PubMed ID: 7550289
    [Abstract] [Full Text] [Related]

  • 19. Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides.
    Kandimalla ER, Manning A, Lathan C, Byrn RA, Agrawal S.
    Nucleic Acids Res; 1995 Sep 11; 23(17):3578-84. PubMed ID: 7567472
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
    Brown-Driver V, Eto T, Lesnik E, Anderson KP, Hanecak RC.
    Antisense Nucleic Acid Drug Dev; 1999 Apr 11; 9(2):145-54. PubMed ID: 10355821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.